Shares of AstraZeneca PLC have moved -4.5% today, and are now trading at a price of $63.57. In contrast, the S&P 500 index saw a 0.0% change. Today's trading volume is 25,225,679 compared to the stock's average volume of 5,509,188.
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, andcommercialization of prescription medicines. Based in Cambridge, United Kingdom the company has 83,500 full time employees and a market cap of $197,091,147,776. AstraZeneca PLC currently offers its equity investors a dividend that yields 4.4% per year.
The company is now trading -22.34% away from its average analyst target price of $81.86 per share. The 10 analysts following the stock have set target prices ranging from $70.0 to $88.0, and on average give AstraZeneca PLC a rating of buy.
Over the last 12 months AZN shares have declined by -1.3%, which represents a difference of -23.7% when compared to the S&P 500. The stock's 52 week high is $76.56 per share and its 52 week low is $61.7. Based on AstraZeneca PLC's average net margin growth of 10.0% over the last 5 years, its core business remains strong and the stock price may recover in the long term.
Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
---|---|---|---|---|
2023 | 11,416,000 | 1,820,000 | 16 | 128.57 |
2022 | 44,351,000 | 3,293,000 | 7 | -46.15 |
2021 | 876,000 | 112,000 | 13 | 8.33 |
2020 | 26,617,000 | 3,144,000 | 12 | 140.0 |
2019 | 24,384,000 | 1,227,000 | 5 | -44.44 |
2018 | 22,090,000 | 2,050,000 | 9 |